The role of Thr139 in the human immunodeficiency virus type 1 reverse transcriptase sensitivity to (+)-calanolide A

被引:14
|
作者
Auwerx, J
Rodríguez-Barrios, F
Ceccherini-Silberstein, F
San-Félix, A
Velázquez, S
De Clercq, E
Camarasa, MJ
Perno, CF
Gago, F
Balzarini, J
机构
[1] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
[2] Univ Alcala de Henares, Dept Pharmacol, Alcala De Henares, Spain
[3] Univ Roma Tor Vergata, Dept Expt Med, Rome, Italy
[4] CSIC, Inst Quim Med, E-28006 Madrid, Spain
关键词
D O I
10.1124/mol.105.012351
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The coumarins represent a unique class of non-nucleoside reverse transcriptase inhibitors (NNRTIs) that were isolated from tropical plants. (+)-Calanolide A, the most potent compound of this class, selects for the T139I resistance mutation in HIV-1 reverse transcriptase (RT). Seven RTs mutated at amino acid position 139 (Ala, Lys, Tyr, Asp, Ile, Ser, and Gln) were constructed by site-directed mutagenesis. The mutant T139Q enzyme retained full catalytic activity compared with wild-type RT, whereas the mutant T139I, T139S, and T139A RTs retained only 85 to 50% of the activity. Mutant T139K, T139D, and T139Y RTs had seriously impaired catalytic activities. The mutations in the T139I and T139D RTs were shown to destabilize the RT heterodimer. (+)-Calanolide A lost inhibitory activity (up to 20-fold) against the mutant T139Y, T139Q, T139K, and T139I enzymes. All of the mutant enzymes retained marked susceptibility toward the other NNRTIs, including nevirapine, delavirdine, efavirenz, thiocarboxanilide UC-781, quinoxaline GW867420X, TSAO [[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5 ''-(4 ''-amino-1 '',2 ''-oxathiole-2 '',2 ''-dioxide)]derivatives, and the nucleoside inhibitor, ddGTP. The fact that the T139I RT 1) proved to be resistant to (+)-calanolide A, 2) represents a catalytically efficient enzyme, and 3) requires only a single transition point mutation (ACA -> ATA) in codon 139 seems to explain why mutant T139I RT virus strains, but not virus strains containing other amino acid changes at this position, predominantly emerge in cell cultures under (+)-calanolide A pressure.
引用
收藏
页码:652 / 659
页数:8
相关论文
共 50 条
  • [31] A Bifunctional Nucleoside Probe for the Inhibition of the Human Immunodeficiency Virus-Type 1 Reverse Transcriptase
    Shaw, Tyler A.
    Ablenas, Christopher J.
    Desrochers, Genevieve F.
    Powdrill, Megan H.
    Bilodeau, Didier A.
    Vincent-Rocan, Jean-Francois
    Niu, Meijuan
    Monette, Anne
    Mouland, Andrew J.
    Beauchemin, Andre M.
    Pezacki, John Paul
    BIOCONJUGATE CHEMISTRY, 2020, 31 (05) : 1537 - 1544
  • [32] An integrated system to study multiply substituted human immunodeficiency virus type 1 reverse transcriptase
    Boretto, J
    Longhi, S
    Navarro, JM
    Selmi, B
    Sire, J
    Canard, B
    ANALYTICAL BIOCHEMISTRY, 2001, 292 (01) : 139 - 147
  • [33] Stabilization of human immunodeficiency virus type 1 reverse transcriptase by site-directed mutagenesis
    Kosaku Nishimura
    Mayu Shinomura
    Atsushi Konishi
    Kiyoshi Yasukawa
    Biotechnology Letters, 2013, 35 : 2165 - 2175
  • [34] REGULATION OF THE REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY DNTPS
    WEST, AB
    ROBERTS, TM
    KOLODNER, RD
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (20) : 9720 - 9724
  • [35] Stabilization of human immunodeficiency virus type 1 reverse transcriptase by site-directed mutagenesis
    Nishimura, Kosaku
    Shinomura, Mayu
    Konishi, Atsushi
    Yasukawa, Kiyoshi
    BIOTECHNOLOGY LETTERS, 2013, 35 (12) : 2165 - 2175
  • [36] The interaction of the reverse transcriptase of human immunodeficiency virus type 1 with 3'-terminally mispaired DNA
    Bakhanashvili, M
    Hizi, A
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1996, 334 (01) : 89 - 96
  • [37] Human immunodeficiency virus type 1 reverse transcriptase and protease mutation search engine for queries
    Robert W. Shafer
    Duane R. Jung
    Bradley J. Betts
    Nature Medicine, 2000, 6 : 1290 - 1292
  • [38] Subunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo
    Mulky, A
    Sarafianos, SG
    Arnold, E
    Wu, XY
    Kappes, JC
    JOURNAL OF VIROLOGY, 2004, 78 (13) : 7089 - 7096
  • [39] Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility
    Apetrei, C
    Descamps, D
    Collin, G
    Loussert-Ajaka, I
    Damond, F
    Duca, M
    Simon, F
    Brun-Vézinet, F
    JOURNAL OF VIROLOGY, 1998, 72 (05) : 3534 - 3538
  • [40] CASSETTE MUTAGENESIS OF THE REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    BOYER, PL
    FERRIS, AL
    HUGHES, SH
    JOURNAL OF VIROLOGY, 1992, 66 (02) : 1031 - 1039